Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
EXOZ eXoZymes Inc.
- Stocks
- Healthcare
- NASDAQ: EXOZ
Price (delayed)
$13.6
Market cap
$113.8M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.96
Enterprise value
$106.62M
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds.
Highlights
The debt has contracted by 48% YoY and by 4.4% from the previous quarter
eXoZymes's net income has plunged by 139% YoY and by 14% from the previous quarter
The EPS has plunged by 113% YoY and by 8% from the previous quarter
Key stats
What are the main financial stats of EXOZ
Market
Valuations
Earnings
Shares outstanding
8.37M
Market cap
$113.8M
Enterprise value
$106.62M
Price to earnings (P/E)
N/A
Price to book (P/B)
12.81
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$6.87M
Net income
-$6.71M
EBIT
-$6.88M
EBITDA
-$6.57M
Free cash flow
-$10.2M
Per share
Balance sheet
Liquidity
EPS
-$0.96
EPS diluted
-$0.96
Free cash flow per share
-$1.22
Book value per share
$1.06
Revenue per share
$0
TBVPS
$1.38
Total assets
$11.53M
Total liabilities
$2.64M
Debt
$1.33M
Equity
$8.88M
Working capital
$7.97M
Debt to equity
0.15
Current ratio
6.52
Quick ratio
6.31
Net debt/EBITDA
1.09
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-83.4%
Return on equity
-199.7%
Return on invested capital
-196.8%
Return on capital employed
-68.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EXOZ stock price
How has the eXoZymes stock price performed over time
Intraday
-4.02%
1 week
-2.86%
1 month
24.89%
1 year
N/A
YTD
-17.58%
QTD
30.14%
Financial performance
How have eXoZymes's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$6.87M
Net income
-$6.71M
Gross margin
N/A
Net margin
N/A
eXoZymes's operating income has plunged by 168% YoY and by 16% from the previous quarter
eXoZymes's net income has plunged by 139% YoY and by 14% from the previous quarter
eXoZymes's revenue has plunged by 100% YoY
The gross profit has dropped by 100% year-on-year
Price vs fundamentals
How does EXOZ's price correlate with its fundamentals
Growth
What is eXoZymes's growth rate over time
Valuation
What is eXoZymes stock price valuation
P/E
N/A
P/B
12.81
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has plunged by 113% YoY and by 8% from the previous quarter
eXoZymes's equity has decreased by 15% from the previous quarter
eXoZymes's revenue has plunged by 100% YoY
Efficiency
How efficient is eXoZymes business performance
eXoZymes's ROIC has plunged by 88% YoY and by 14% from the previous quarter
The ROE has soared by 72% from the previous quarter
EXOZ's ROA is down by 19% YoY but it is up by 12% from the previous quarter
Dividends
What is EXOZ's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EXOZ.
Financial health
How did eXoZymes financials performed over time
eXoZymes's total assets has soared by 188% YoY but it has decreased by 12% from the previous quarter
EXOZ's total liabilities is down by 50% YoY
The debt is 85% less than the equity
EXOZ's debt to equity has soared by 107% YoY and by 15% QoQ
The debt has contracted by 48% YoY and by 4.4% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.